abacavir

Generic: abacavir

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abacavir
Generic Name abacavir
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

abacavir sulfate 300 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-557
Product ID 31722-557_2b451c79-7df8-d0f9-e063-6294a90a5fcf
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091560
Listing Expiration 2026-12-31
Marketing Start 2021-04-01

Pharmacologic Class

Classes
cytochrome p450 1a1 inhibitors [moa] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722557
Hyphenated Format 31722-557

Supplemental Identifiers

RxCUI
242679
UPC
0331722557603
UNII
J220T4J9Q2

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abacavir (source: ndc)
Generic Name abacavir (source: ndc)
Application Number ANDA091560 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (31722-557-60)
source: ndc

Packages (1)

31722-557-60 60 TABLET in 1 BOTTLE (31722-557-60)

Ingredients (1)

abacavir sulfate (300 mg/1)

Linked Drug Pages (1)

Abacavir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b451c79-7df8-d0f9-e063-6294a90a5fcf", "openfda": {"upc": ["0331722557603"], "unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["44fb1e25-ad03-4a7f-9f35-2e29f5025661"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (31722-557-60)", "package_ndc": "31722-557-60", "marketing_start_date": "20210401"}], "brand_name": "Abacavir", "product_id": "31722-557_2b451c79-7df8-d0f9-e063-6294a90a5fcf", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-557", "generic_name": "Abacavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA091560", "marketing_category": "ANDA", "marketing_start_date": "20210401", "listing_expiration_date": "20261231"}